| [1] |
CHOU S, ALAIN S, CERVERA C, et al. Drug resistance assessed in a phase 3 clinical trial of maribavir therapy for refractory or resistant cytomegalovirus infection in transplant recipients[J]. J Infect Dis, 2024, 229(2):413-421.
DOI
URL
|
| [2] |
何瑞芬, 马雯, 梁爱玲, 等. HCMV-DNA定量检测和HCMV-IgG抗体AI检测在儿童HCMV感染诊断中的临床价值[J]. 现代生物医学进展, 2022, 22(4):737-740.
|
| [3] |
中华医学会围产医学分会, 中华医学会妇产科学分会产科学组, 《中华围产医学杂志》编辑委员会. 妊娠期巨细胞病毒感染筛查与处理专家共识[J]. 中华围产医学杂志, 2017, 20(8):553-556.
|
| [4] |
邱佩绵, 梁雪雁, 温瑛梦, 等. 妊娠早期巨细胞病毒感染和产前诊断案例分析[J]. 国际妇产科学杂志, 2022, 49(6):675-678.
|
| [5] |
Society for Maternal-Fetal Medicine(SMFM), HUGHES B L, GYAMFI-BANNERMAN C. Diagnosis and antenatal management of congenital cytomegalovirus infection[J]. Am J Obstet Gynecol,2016 Jun, 214(6):B5-B11.
DOI
URL
|
| [6] |
吴培豪, 周俞, 吴开奇, 等. 巨细胞病毒感染新生儿血清IgM抗体和病毒载量与临床症状的相关性研究[J]. 中华预防医学杂志, 2022, 56(11):1642-1647.
|
| [7] |
郭靖, 赵祖英. 血清游离人绒毛膜促性腺激素水平与宫内感染巨细胞病毒的相关性分析[J]. 中国妇幼保健, 2022, 37(2):217-219.
|
| [8] |
WU K, HOU Y J, MAKRINOS D, et al. Characterization of humoral and cellular immunologic responses to an mRNA-based human cytomegalovirus vaccine from a phase 1 trial of healthy adults[J]. J Virol, 2024, 98(4):160323.
|
| [9] |
强玉娜, 吕树志, 邢祝乔, 等. 巨细胞病毒感染与冠心病重症患者血液流变学和内毒素水平及预后的关系[J]. 中华医院感染学杂志, 2022, 32(23):3562-3566.
|
| [10] |
VIANA L A, CRISTELLI M P, BASSO G, et al. Conversion to mTOR inhibitor to reduce the incidence of cytomegalovirus recurrence in kidney transplant recipients receiving preemptive treatment:a prospective,randomized trial[J]. Transplantation, 2024, 108(4):63.
|
| [11] |
ZAMORA D, DASGUPTA S, STEVENS-AYERS T, et al. Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis[J]. JCI Insight, 2024, 9(18):180115.
|
| [12] |
刘鑫, 金米聪. 宁波地区5 497例人巨细胞病毒荧光定量PCR检测结果分析[J]. 中国卫生检验杂志, 2022, 32(19):2386-2388.
|
| [13] |
SINGH N, WINSTON D J, RAZONABLE R R, et al. Unexpected cytomegalovirus(CMV)replication kinetics in CMV donor-seropositive,recipient-seronegative liver transplant recipients receiving preemptive antiviral therapy[J]. J Infect Dis, 2022, 225(3):436-442.
DOI
URL
|
| [14] |
陈思敏, 刘鹏飞, 陆立东, 等. 婴儿巨细胞病毒感染性肝炎病毒载量与γ-GGT的相关性及其对预后预测价值[J]. 河北医科大学学报, 2022, 43(12):1454-1458.
|
| [15] |
PARENTE P, ASCANI S, MAIORANO B A, et al. Letter:be careful of gastrointestinal CMV infection in adverse events from ICIs therapy in solid tumours[J]. Aliment Pharmacol Ther, 2023, 57(8):916-917.
DOI
URL
|
| [16] |
李雪国, 王如民, 徐艳芳, 等. 新疆地区儿童异基因造血干细胞移植后巨细胞病毒感染相关危险因素分析[J]. 中国小儿血液与肿瘤杂志, 2023, 28(4):243-247.
|
| [17] |
罗芸, 陈晶, 夏乐莎, 等. 巨细胞病毒感染性流产IL-1、TLR4、E-cadherin基因的表达及意义[J]. 中华医院感染学杂志, 2021, 31(7):1071-1075.
|